Piezoelectric‐Triggered Ferroptosis for Cancer Therapy via Cascade‐Enhanced Immune Response
Advanced Healthcare Materials · 2025-05 · 14 (14)
DOI: 10.1002/adhm.202501339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 02.05.2025. Verfasst von Huijuan Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Eye Health, Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, …. Hauptthemen laut MEDLINE: Ferroptosis, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Innovative Research Team of High-level Local University in Shanghai.
Abstract (Originalsprache)
Eliciting ferroptotic cell death in tumors has enhanced prospects for cancer therapy because of its proinflammatory properties, which enable damage‐associated molecular pattern (DAMP) release and immune response activation. However, the immunogenicity of ferroptosis and how to controllably activate the self‐enhanced antitumor immune response by cellular ferroptosis require further investigation. In this study, a piezoelectric BaTiO 3 ‐based ferroptosis inducer (BTO@Fe) is synthesized for effective cancer immunotherapy. BTO@Fe induces moderate ferroptosis by introducing excess iron and catalyzing the Fenton reaction. When subjected to ultrasound (US) irradiation, the piezoelectrically excited electrons and holes are separated, further catalyzing reactive oxygen species (ROS) generation and glutathione (GSH) consumption and consequently causing intensified ferroptosis and immunogenic cell death (ICD). Moreover, activated CD8 + T cells respond to immune signals by releasing interferon gamma (IFNγ), which sensitizes tumor cells to ferroptosis in an intrinsic mechanism of ferroptosis initiation. The robust ferroptosis originating from exogenous piezocatalytic reactions and the endogenous immune responses demonstrates satisfactory in vitro and in vivo antitumor effects. This work suggests that doping‐engineered piezoelectric materials with augmented catalytic activity are promising countermeasures for restoring immunogenicity in ferroptotic cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Eye Health, Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, P. R. China.
- Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai, 200025, P. R. China.
- Department of Ophthalmology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, P. R. China.
ORCID-Profile: Huijuan Zheng, Huimin Lin, Fan Yang, Jing Ruan, Renbing Jia
Förderung
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- Innovative Research Team of High-level Local University in Shanghai
- Shanghai Eye Disease Research Center
Zitieren
APA
Zheng, H., Lin, H., Ke, Y., Ma, Y., Ge, S., Yang, F., Ruan, J., & Jia, R. (2025). Piezoelectric‐Triggered Ferroptosis for Cancer Therapy via Cascade‐Enhanced Immune Response. Advanced Healthcare Materials, 14(14). https://doi.org/10.1002/adhm.202501339
Vancouver
Zheng H, Lin H, Ke Y, Ma Y, Ge S, Yang F, et al. Piezoelectric‐Triggered Ferroptosis for Cancer Therapy via Cascade‐Enhanced Immune Response. Advanced Healthcare Materials. 2025;14(14). doi:10.1002/adhm.202501339
BibTeX
@article{Zheng2025,
author = {Zheng, Huijuan and Lin, Huimin and Ke, Yun and Ma, Yawen and Ge, Shengfang and Yang, Fan and Ruan, Jing and Jia, Renbing},
title = {Piezoelectric‐Triggered Ferroptosis for Cancer Therapy via Cascade‐Enhanced Immune Response},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {14},
doi = {10.1002/adhm.202501339}
}
EUVIMED